Registration - Organization

Incyte Biosciences Canada Corporation / Christine Lennon, General Manager Canada

Registration Information

Organization name: Incyte Biosciences Canada Corporation
Senior Officer Name: Christine Lennon, General Manager Canada
Initial registration start date: 2022-06-20
Registration status: Active
Projected end date: No date provided
Registration number: 8900-4685

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 4

Lobbying Activity Reports - last 6 months: 0

Version 2 of 3 (2023-12-01 to 2024-10-31)

Registration versions:

Version 2 of 3 (2023-12-01 to 2024-10-31)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Discuss innovative agreements for reimbursement and the use of RWE in evaluation of pharmaceutical products.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Finances and Budgets, Health, Hospitals, Science and Technology, Senior Citizens
Educate government stakeholders about life-science strategies and policies that impact access to innovative medicines.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health, Hospitals, Senior Citizens
Educate on the unmet needs of rare cancers and how to facilitate improved processes within the government to allow for innovation in rare diseases.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Hospitals, Science and Technology
Explain the need for expanded Next Generation Sequencing tests in order to provide innovative personalized cancer care to BC patients.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Hospitals, Science and Technology
Identify changes to pharmaceutical legislation supporting appropriate government reimbursement of medicines.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Health, Hospitals, Science and Technology, Senior Citizens
Raise awareness of the value that innovative medicines provide and demonstrate that Incyte Biosciences Canada supports the growth of the life-science sector in BC.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health, Hospitals, Science and Technology

BC Ministries/Provincial Entities

Fraser Health Authority
Health
Innovate BC
Member(s) of the BC Legislative Assembly
Office of the Premier
Parliamentary Secretary for Seniors' Services and Long-Term Care
Providence Health Care Society
Provincial Health Services Authority
University of British Columbia
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Organization Details

Senior Officer Name and Position during the Period of this Registration

Christine Lennon, General Manager Canada

Organization Contact Information

Incyte Biosciences Canada Corporation

Address:
6500 TransCanada Highway
Suite 400
Pointe Claire, QC H9R 0A5
Canada

Telephone number: 514-862-1662

Description of Activities

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 1500 people and have operations in the U.S., Canada, Europe and Japan.

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was requested or received within the preceding 12 months.

Coalition Members Information

Incyte Biosciences Canada Corporation is not a coalition member.

Affiliates with a Direct Interest in the Outcome

Incyte Coporation
- 1801 Augustine Cut-off
  Wilmington, DE 19803
  United States of America

Other Persons or Organizations with Direct Interests

The activities of Incyte Biosciences Canada Corporation are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Details

Lobbyists Employed by this Organization

Lobbyist

Contributions

Cheryl Bielicz
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Barry Flannelly
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Christine Lennon
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Sam Stankovic
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization on or after 2020-09-21 and before 2024-09-21: Yes

Political: No
Sponsorship: No
Recall: No

Incyte Biosciences Canada Corporation

Name change history

Name change history
Name	From	To
Incyte Biosciences Canada Corporation	2022-06-20	current

Incyte Biosciences Canada Corporation

Senior Officer History
Senior Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Christine Lennon, General Manager Canada (Organization)

Learn more...

Designated Filers are required to submit a Lobbying Activity Report for each lobbying activity with a senior public officer holder. The name of the most senior paid officer (i.e. the designated filer) will appear on all in-house Lobbying Activity Reports, whether or not he/she participated in the activity.

Note: Lobbying Activity Reports are due on the 15^th day of each month for lobbying activities that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-4 of 4

Incyte Biosciences Canada Corporation
Organization

Senior Public Office Holders who were lobbied in this activity:
- Mitch Moneo, Assistant Deputy Minister | Provincial Health Services Authority
Lobbying Activity date: 2023-05-26
Lobbyists who performed the lobbying activity: Cheryl Bielicz, Sam Stankovic
Posted date: 2023-06-08
Lobbying Activity number: 4685-26536 View Lobbying Activity Report
Incyte Biosciences Canada Corporation
Organization

Senior Public Office Holders who were lobbied in this activity:
- Mitch Moneo, Assistant Deputy Minister | Health
Lobbying Activity date: 2023-04-11
Lobbyists who performed the lobbying activity: Cheryl Bielicz
Posted date: 2023-04-12
Lobbying Activity number: 4685-24987 View Lobbying Activity Report
Incyte Biosciences Canada Corporation
Organization

Senior Public Office Holders who were lobbied in this activity:
- Mitch Moneo, Assistant Deputy Minister | Health
Lobbying Activity date: 2022-07-19
Lobbyists who performed the lobbying activity: Cheryl Bielicz
Posted date: 2022-07-27
Lobbying Activity number: 4685-20002 View Lobbying Activity Report
Incyte Biosciences Canada Corporation
Organization

Senior Public Office Holders who were lobbied in this activity:
- Mitch Moneo, Assistant Deputy Minister | Health
Lobbying Activity date: 2022-06-20
Lobbyists who performed the lobbying activity: Cheryl Bielicz, Sam Stankovic
Posted date: 2022-07-15
Lobbying Activity number: 4685-19433 View Lobbying Activity Report

Date Modified:: 2024-11-13

Menus

www.lobbyistsregistrar.bc.ca

Registration - Organization

Incyte Biosciences Canada Corporation / Christine Lennon, General Manager Canada

Registration Information

Associated Lobbying Activity Reports

Version 2 of 3 (2023-12-01 to 2024-10-31)

Version 2 of 3 (2023-12-01 to 2024-10-31)

Details Regarding the Identified Subject Matter

BC Ministries/Provincial Entities

Senior Officer Name and Position during the Period of this Registration

Organization Contact Information

Description of Activities

Gifts or benefits provided by the organization

Contributors to the Lobbying Activity

Government Funding in the Last 12 Months

Coalition Members Information

Affiliates with a Direct Interest in the Outcome

Other Persons or Organizations with Direct Interests